CDK4/6 and SHP2 mediate BRAF/MEK inhibitor resistance in Class 2 and 3 BRAF mutant cancers
April A. N. Rose, Jennifer Maxwell, Emmanuelle Rousselle, Melody Riaud, Islam E. Elkholi, Chantel Mukonoweshuro, Marco Biondini, Erica Cianfarano, Isabel Soria-Bretones, Chantal Tobin, Meghan McGuire, Ian King, Tong Zhang, Trevor J. Pugh, Zaid Saeed Kamil, Frances A. Shepherd, Natasha Leighl, Albiruni Abdul Razak, Aaron Hansen, Sam Saibil, Philippe Bedard, Peter M. Siegel, Lillian L. Siu, David W. Cescon, Anna Spreafico
medRxiv 2024.07.28.24311101; doi: https://doi.org/10.1101/2024.07.28.24311101